From entrepreneurial leaps to the future of bypass, the most powerful moments from the past months are here. In this best-of episode, we revisit conversations with some of the sharpest minds in MedTech, vascular surgery, cardiology, and education, including ICHOR Founder and CEO Tim Blair, interventional cardiologist Dr. Jaafer Golzar, interventional angiologist Dr. Michael Lichtenberg, bilingual parenting expert Michelle Bruni and Scott Addonizio, COO of BrosMed Medical and President of BrosMed US. Each guest shares something unforgettable: what it really takes to build a company from scratch, when to push for new treatment paths, how to think differently about bypass, and why raising a bilingual child is more science-backed than most experts still realize. We also hear from Life of Flow Podcast hosts Miguel and Lucas themselves reflecting on the pressure of high-stakes surgery, the value of micro-breaks, and what they’d change about how surgeons are trained today. ♦️ 00:46 The #1 Mistake Founders Make With Their Startups | LOF #71 02:15 What pushed Tim Blair to walk away from a secure MedTech career 04:48 Taking the leap: navigating risk, payroll, and belief ♦️ 11:45 The Procedure That’s Forcing Surgeons to Rethink Bypass | LOF #72 13:50 PTAB: the new bypass option that changed Dr. Golzar’s practice 17:01 When surgeons might consider PTAB over open bypass ♦️ 20:57 This World-Renowned Doctor Is Exposing the Biggest Flaw in Modern Vascular Care | LOF #73 23:00 What vascular care needs less (and more) of 25:49 Young patients, disabling disease, and no viable answers ♦️ 29:07 Should You Raise Your Kid Bilingual? Bilingual Expert Reveals What Parents Miss | LOF #74 29:37 Michelle Bruni explains the best age to start bilingual parenting 31:48 Common myths around speech delays in bilingual kids ♦️ 35:29 Why Surgeons Are Obsessed With This AI Tool | LOF #75 35:42 The worst advice Miguel ever received in training 38:25 Miguel’s spiritual ritual before the OR ♦️45:51 Trump’s Tariffs Are Crippling MedTech - Here’s What Comes Next | LOF #77 46:04 What it felt like when MedTech tariffs suddenly hit 145% 53:18 His vision for future-proofing BrosMed with U.S. manufacturing 💡 Who Should Listen Vascular surgeons, MedTech founders, interventional cardiologists, and early-career physicians looking for raw, honest reflections on career pivots, clinical decision-making, and the future of patient care. About our Guests Timothy Blair is the CEO and Co-Founder of ICHOR Vascular Inc., developing novel approaches to thrombectomy in the peripheral vascular system. He brings 33+ years of experience across leadership roles in sales, marketing, clinical strategy, and venture due diligence, with a background at Smiths Medical, AngioDynamics, and NAMSA. Dr. Jaafer Golzar is an interventional cardiologist, Director of Limb Salvage & Endovascular Intervention at Advocate Trinity Hospital, and Clinical Assistant Professor of Medicine at the University of Illinois at Chicago. His expertise includes endovascular interventions and clinical trial leadership across multiple specialties. Dr. Michael Lichtenberg is a German interventional angiologist with two decades of experience and a former President of the German Society for Angiology. He is known for his work evaluating new tools for peripheral artery disease and his role in founding PEO, CLI-congress, and the European MedTech Startup SharkTank. Michelle Bruni is a bilingual parenting educator and PhD psychologist helping families raise confident bilingual children. She blends science and storytelling through her online education platform and personal parenting experience. Scott Addonizio is COO of BrosMed Medical and President of BrosMed US, with prior leadership roles at MedAlliance, Cordis, and OrbusNeich. His experience spans global supply chains, IDE approvals, and U.S. manufacturing strategy for vascular devices. Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast We appreciate you being here! More to come.

World-renowned vascular surgeon Dr. José Antonio Muñoa Prado chose to begin his medical journey in the most unlikely of places... the heart of the Mexican jungle during the Zapatista uprising. In this episode, he shares the raw, often surreal stories from his early years working in Chiapas, MX, living through armed conflict, delivering care in deeply divided communities, and learning first-hand what it means to serve. From organizing 36 local health councils in divided communities to flying into remote jungle villages during outbreaks, Dr. Muñoa shares how those early years shaped his approach to medicine, problem-solving, and what it really means to serve. 🎧 If you’ve ever wondered what it’s like to deliver care in the middle of a conflict zone, or how those experiences shape who you become as a doctor, this one’s for you! 00:00 Intro 03:16 Why a young doctor chose to enter a war zone 05:29 The Zapatista uprising and its roots 08:50 Seeking identity, history, and something real 14:00 The short war and lingering tension 15:02 Altamirano: gateway to the jungle 27:29 What still stays with him from those years 29:43 Off-road surgery and rural surgical campaigns 39:35 The “attack” that turned out to be something else... 47:12 Why he left, and what stayed with him 50:01 The problem of undocumented knowledge 52:47 Why skills matter more than tech 54:01 The dream of returning, this time with a mic 💡 Who Should Listen For vascular surgeons, public health workers, and early-career physicians curious about what it really means to serve in underserved areas, and how those experiences shape who you become in the OR and beyond. About Dr. José Antonio Muñoa Prado Dr. José Antonio Muñoa Prado is a world-renowned vascular surgeon specializing in diabetic foot, limb salvage, and vein care. He is the former President of the Mexican Association of Vascular Surgeons and the Association of Diabetic Foot, and co-founder of HENDOLAT. With more than 20 years as a pioneering surgeon, educator, and entrepreneur, Dr. Muñoa continues to lead surgical campaigns across rural Mexico and push for innovation that reflects the real-world needs of Latin American communities. Connect with Dr. Muñoa 📲 Instagram: @Dr.Munoa 👍 Facebook: @DrMunoaPrado 💼 LinkedIn: José Antonio Muñoa Prado Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this one gave you a new perspective or brought back a memory, share it with a colleague who’s been there, and if you’re finding value in these conversations, a quick review goes a long way.

In this week’s episode, Scott Addonizio gives a candid look at what it’s like to run a MedTech company when tariffs spike overnight. Disrupting supply chains, inflating costs, and forcing urgent business decisions. He shares how he navigated a 145% import tax on Chinese-made devices, protected customers from cost hikes, and why building U.S. manufacturing might be the only way forward. From OEM and ODM contracts to automation and global supply chain strain, Scott breaks down the pressure points companies are facing now, and what’s coming next. 🎧 If you’ve ever wondered how MedTech companies actually respond when policy shifts overnight, or what it takes to protect your margins and keep moving, this one’s for you. 00:00 Welcome back, Scott! 02:15 Tariff shock: what happened on “Liberation Day” 04:12 How BrosMed absorbed costs instead of passing them on 09:46 Why U.S. manufacturing is now on the table 12:32 Making business decisions in a volatile political climate 26:10 Best and worst-case scenarios for MedTech companies 31:33 Why automation is the only viable way forward 34:47 When the pain will show up: timeline for impact 💡 Who Should Listen This episode is for MedTech founders, device manufacturers, supply chain leads, and physicians working in outpatient settings who want a real look at global pressure on U.S. markets. About Scott Addonizio Scott Addonizio is the Chief Operating Officer of BrosMed Medical, a global manufacturer of devices for vascular disease with a strong focus on lesion preparation. He also serves as President of BrosMed US, where he launched the company's executive and sales operations in Irvine, California. Previously, Scott was COO of MedAlliance, where he helped raise $50 million, led operations for the SELUTION drug-coated balloon, and secured four IDE approvals before the company was acquired by Cordis in 2024. He then served as Senior VP Operations at Cordis before moving to BrosMed. Scott is also acting COO at Solvein, a vein ablation start-up, and board member at Simpson Intervention, guiding sales strategy. Earlier in his career, he was COO and board director at OrbusNeich Medical, where he co-designed key devices like JADE, Sapphire, and Scoreflex Balloons, and held the primary patent for the “Stent Having Dual Helical Design.” He holds a B.S. in Packaging and Materials Engineering from Michigan State University and a Master’s in International Business from the University of Miami. Connect with Scott 🌐 usa.brosmed.com 💼 LinkedIn: Scott Addonizio Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this one made you rethink how fast things can shift in MedTech, and what it actually takes to keep things moving, send it to a colleague who’s living it too. And if you’re getting value from these conversations, a quick review helps us keep them going!